Relationship Between Plasma Lipopolysaccharides, Gut Microbiota, and Dementia: A Cross-Sectional Study
Authors:
- 19 April 2022
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 86 (4) , 1947-1957
Abstract
Background: Previous studies have demonstrated associations between gut microbiota, microbial metabolites, and cognitive decline. However, relationships between these factors and lipopolysaccharides (LPS; molecules of the outer membrane of gram-negative bacteria) remain controversial. Objective: To evaluate associations between plasma LPS, gut microbiota, and cognitive function. Methods: We performed a cross-sectional sub-analysis of data of 127 participants (women: 58%, mean age: 76 years) from our prospective cohort study regarding the relationship between gut microbiota and cognitive function. We enrolled patients who visited our memory clinic and assessed demographics, dementia-related risk factors, cognitive function, brain imaging, gut microbiomes, and microbial metabolites. We evaluated relationships between cognitive decline and plasma LPS using multivariable logistic regression analyses. Results: Plasma LPS concentration increased with increasing degree of cognitive decline and total cerebral small vessel disease (SVD) score (Kruskal-Wallis test; p = 0.016 and 0.007, respectively). Participants with high plasma LPS concentrations tended to have lower concentrations of gut microbial metabolites, such as lactic acid and acetic acid, and were less likely to consume fish and shellfish (44.7% versus 69.6%, p = 0.027) than those with low plasma LPS concentrations. Multivariable analyses revealed that plasma LPS concentration was independently associated with the presence of mild cognitive impairment in participants without dementia (odds ratio: 2.09, 95% confidence interval: 1.14–3.84, p = 0.007). Conclusion: In this preliminary study, plasma LPS concentration was associated with both cognitive decline and cerebral SVD and significantly correlated with beneficial gut microbial metabolites. Plasma LPS may be a risk factor for cognitive decline.Keywords
This publication has 45 references indexed in Scilit:
- Comparison of arteriosclerotic indicators in patients with ischemic stroke: ankle–brachial index, brachial–ankle pulse wave velocity and cardio–ankle vascular indexHypertension Research, 2015
- Cerebral Small Vessel Disease and Arterial Stiffness: Tsunami Effect in the BrainPulse, 2015
- Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burdenNeurology, 2014
- Serum docosahexaenoic and eicosapentaenoic acid and risk of cognitive decline over 10 years among elderly JapaneseEuropean Journal of Clinical Nutrition, 2014
- Prediction of outcomes in MCI with 123I-IMP-CBF SPECT: a multicenter prospective cohort studyAnnals of Nuclear Medicine, 2013
- Discrimination of dementia with Lewy bodies from Alzheimer’s disease using voxel-based morphometry of white matter by statistical parametric mapping 8 plus diffeomorphic anatomic registration through exponentiated Lie algebraNeuroradiology, 2013
- Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairmentPsychiatry and Clinical Neurosciences, 2012
- Automatic Voxel-Based Morphometry of Structural MRI by SPM8 plus Diffeomorphic Anatomic Registration Through Exponentiated Lie Algebra Improves the Diagnosis of Probable Alzheimer DiseaseAmerican Journal of Neuroradiology, 2012
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Mapping Scores Onto Stages: Mini-Mental State Examination and Clinical Dementia RatingThe American Journal of Geriatric Psychiatry, 2006